Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Hormonal blood tests revealed significantly higher serum testosterone levels in the AG compared to the NPG (0.50 ng/mL vs. 0.275 ng/mL, Hedge's effect size = 0.28, p = 0.0057), with no significant differences in estradiol, prolactin, or vitamin D levels (Table 3).

Source: Hormonal and metabolic blood values. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

The Autism Group (AG) was recruited consecutively, including all individuals with an ASD diagnosis who met the inclusion criteria, until a total of 50 participants was reached.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Steroidopathies and hormonal imbalance in children and adolescents with autism spectrum disorder

Study design awaiting verification · JCPP Advances · 2025

Original publication title

Steroidopathies and hormonal imbalance in children and adolescents with autism spectrum disorder

Concetta de Giambattista; Patrizia Ventura; Samuele Cortese; Paolo Trerotoli; Alessandra Di Gioia; Lucia Margari

© 2025 The Author(s). JCPP Advances published by John Wiley & Sons Ltd on behalf of Association for Child and Adolescent Mental Health.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

These findings support the hypothesis of an association between steroidopathies and altered steroid hormone levels with ASD, suggesting that steroid hormone profiles could potentially serve as early biomarkers in future research. Furthermore, consideration of maternal endocrine health and prenatal exposures may contribute to a better understanding of ASD risk.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition with a multifactorial etiology, many aspects of which remain unclear. Emerging evidence suggests a potential association between ASD and clinical manifestations resulting from hormonal imbalances, henceforth named “steroidopathies.” The present study aims to investigate the association between ASD, steroidopathies and altered steroid hormone levels.

Source: Background

Abstract: What methods does the paper describe?

A cohort of 100 individuals aged 9 to 18 years was examined, comprising 50 autistic individuals (25 males, 25 females) compared to 50 individuals diagnosed with other neuropsychiatric disorders (20 males, 30 females). Data were collected on steroidopathies (including hirsutism, severe acne, irregular menstrual cycles, polycystic ovary syndrome, endometriosis, pubertal disorders) in participants and their first‐degree relatives, as well as on maternal pregnancy and delivery complications. Blood samples were analyzed to assess hormonal profiles, including testosterone, estradiol, and vitamin D levels. A multivariate logistic regression analysis was conducted, with ASD status as the dependent variable and hormone levels, steroidopathies and other pregnancy‐related conditions as independent variables.

Sex and age were included as covariates.

Source: Methods

Abstract: Results

The results indicate a higher prevalence of steroidopathies among relatives of individuals with ASD compared to those with other neuropsychiatric disorders, with statistically significant differences in the frequency of thyroid pathologies (OR = 2.66, 95% CI: 1.05 to 6.76, p = 0.0394) and a borderline effect for maternal hormonal treatment during pregnancy (OR = 3.17, 95% CI: 0.99 to 10.08, p = 0.0501). Serum testosterone levels were significantly higher in autistic individuals compared to controls (median 0.50 vs. 0.275 ng/mL, p = 0.0057).

Source: Results

Abstract: Conclusion

These findings support the hypothesis of an association between steroidopathies and altered steroid hormone levels with ASD, suggesting that steroid hormone profiles could potentially serve as early biomarkers in future research. Furthermore, consideration of maternal endocrine health and prenatal exposures may contribute to a better understanding of ASD risk.

Source: Conclusion
Authors’ abstract

Abstract

Background

Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition with a multifactorial etiology, many aspects of which remain unclear. Emerging evidence suggests a potential association between ASD and clinical manifestations resulting from hormonal imbalances, henceforth named “steroidopathies.” The present study aims to investigate the association between ASD, steroidopathies and altered steroid hormone levels.

Methods

A cohort of 100 individuals aged 9 to 18 years was examined, comprising 50 autistic individuals (25 males, 25 females) compared to 50 individuals diagnosed with other neuropsychiatric disorders (20 males, 30 females). Data were collected on steroidopathies (including hirsutism, severe acne, irregular menstrual cycles, polycystic ovary syndrome, endometriosis, pubertal disorders) in participants and their first‐degree relatives, as well as on maternal pregnancy and delivery complications. Blood samples were analyzed to assess hormonal profiles, including testosterone, estradiol, and vitamin D levels. A multivariate logistic regression analysis was conducted, with ASD status as the dependent variable and hormone levels, steroidopathies and other pregnancy‐related conditions as independent variables.

Sex and age were included as covariates.

Results

The results indicate a higher prevalence of steroidopathies among relatives of individuals with ASD compared to those with other neuropsychiatric disorders, with statistically significant differences in the frequency of thyroid pathologies (OR = 2.66, 95% CI: 1.05 to 6.76, p = 0.0394) and a borderline effect for maternal hormonal treatment during pregnancy (OR = 3.17, 95% CI: 0.99 to 10.08, p = 0.0501). Serum testosterone levels were significantly higher in autistic individuals compared to controls (median 0.50 vs. 0.275 ng/mL, p = 0.0057).

Conclusion

These findings support the hypothesis of an association between steroidopathies and altered steroid hormone levels with ASD, suggesting that steroid hormone profiles could potentially serve as early biomarkers in future research. Furthermore, consideration of maternal endocrine health and prenatal exposures may contribute to a better understanding of ASD risk.

Key points

What's known?

  • Emerging evidence suggests a link between steroid hormone dysregulation and Autism Spectrum Disorder (ASD).

  • Elevated prenatal androgens, such as testosterone, have been observed in individuals later diagnosed with ASD.

  • Steroid‐related conditions like polycystic ovary syndrome (PCOS) appear more frequently in mothers or female relatives of individuals with ASD.

What's new?

  • The present study investigates the relationship between ASD, steroidopathies, and steroid hormone profiles in a well‐characterized, homogeneous cohort balanced for age and sex.

  • By including first‐degree relatives, it assesses potential familial hormonal patterns.

  • To determine whether these hormonal alterations are specific to ASD, the study compares the ASD group with a homogeneous group of individuals diagnosed with other neuropsychiatric conditions.

  • The inclusion of a balanced male/female ratio and first‐degree relatives in the sample represents a methodological strength, as autistic females are often underrepresented and few studies investigate familial patterns, which limits insights into potential hereditary contributions to ASD.

What's relevant?

  • This study provides evidence supporting a potential link between hormonal imbalances and ASD, emphasizing the need for further investigation into steroid hormone roles in neurodevelopmental pathways.

  • The findings identify potential early biomarkers to support diagnosis and preventive strategies.

  • Results emphasize the importance of improving prenatal care protocols and integrating hormonal profiling into ASD diagnosis and management frameworks.

Publication and source details

Original title: Steroidopathies and hormonal imbalance in children and adolescents with autism spectrum disorder

Concetta de Giambattista; Patrizia Ventura; Samuele Cortese; Paolo Trerotoli; Alessandra Di Gioia; Lucia Margari

JCPP Advances · 2025

* Correspondence
Samuele Cortese, Universita degli Studi di Bari Aldo Moro Dipartimento di Medicina di Precisione e Rigenerativa e Area Jonica, Bari, Italy.
Email: samuele.cortese@gmail.com
Lucia Margari, Universita degli Studi di Bari Aldo Moro Dipartimento di Medicina di Precisione e Rigenerativa e Area Jonica, Bari, Italy.
Email: lucia.margari@uniba.it
© 2025 The Author(s). JCPP Advances published by John Wiley & Sons Ltd on behalf of Association for Child and Adolescent Mental Health.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. NIHR NIHR303122NIHR203684NIHR203035NIHR130077NIHR128472RP‐PG‐0618‐20003 European Research Executive Agency 101095568‐HORIZONHLTH‐ 2022‐DISEASE‐07‐03

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T23:20:58.630797+00:00

DOI: 10.1002/jcv2.70070 · PMC13339666